CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −1,762 | $76.25 | $134K | 39,160 |
| 2026-01-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $84.33 | $42K | 74,374 |
| 2025-12-18 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,622 | $82.40 | $134K | 58,564 |
| 2025-12-12 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $82.32 | $33K | 74,874 |
| 2025-12-05 | TANNENBAUM RENEE P Director | Sale | −1,800 | $81.15 | $146K | 25,157 |
| 2025-11-13 | Walsh Patrick D Director | Sale | −8,643 | $86.88 | $751K | 61,405 |
| 2025-11-13 | Walsh Patrick D Director | Gift | −3,000 | 58,405 | ||
| 2025-11-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $87.27 | $35K | 75,274 |
| 2025-11-13 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −94 | $88.00 | $8K | 158,490 |
| 2025-11-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −14,642 | $89.07 | $1.3M | 158,584 |
| 2025-10-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $90.09 | $36K | 75,674 |
| 2025-09-19 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,000 | $98.04 | $98K | 60,186 |
| 2025-09-12 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,710 | $97.71 | $167K | 61,186 |
| 2025-09-12 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $98.42 | $39K | 76,074 |
| 2025-09-03 | Pera Antonio R Director | Sale | −7,292 | $94.94 | $692K | 22,660 |
| 2025-08-25 | Leonard Matthew J Director | Sale | −2,528 | $90.62 | $229K | 6,864 |
| 2025-08-22 | Davis Krista SVP, CHIEF HR OFFICER | Sale | −1,763 | $91.10 | $161K | 62,896 |
| 2025-08-21 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale | −52,988 | $90.44 | $4.8M | 431,920 |
| 2025-08-20 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale | −47,012 | $90.27 | $4.2M | 484,908 |
| 2025-08-20 | Pera Antonio R Director | Sale | −5,421 | $89.73 | $486K | 29,952 |
Page 6 of 15 · 282 trades